title: Author reply: To PMID 24393349.
authors.affiliation: Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota. Electronic address: bakri.sophie@mayo.edu.
authors.forename: Sophie J
authors.initials: SJ
authors.lastname: Bakri
authors.affiliation: Byers Eye Institute at Stanford University, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California.
authors.forename: Darius M
authors.initials: DM
authors.lastname: Moshfeghi
authors.affiliation: Genentech Inc., South San Francisco, California.
authors.forename: Steve
authors.initials: S
authors.lastname: Francom
authors.affiliation: Genentech Inc., South San Francisco, California.
authors.forename: Amy Chen
authors.initials: AC
authors.lastname: Rundle
authors.affiliation: Genentech Inc., South San Francisco, California.
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Reshef
authors.affiliation: Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.
authors.forename: Paul P
authors.initials: PP
authors.lastname: Lee
authors.affiliation: Genentech Inc., South San Francisco, California.
authors.forename: Carol
authors.initials: C
authors.lastname: Schaeffer
authors.affiliation: Genentech Inc., South San Francisco, California.
authors.forename: Roman G
authors.initials: RG
authors.lastname: Rubio
authors.affiliation: Genentech Inc., South San Francisco, California.
authors.forename: Phillip
authors.initials: P
authors.lastname: Lai
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology*; D008297:Male; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized